Prostate cancer: endogenous chemical castration.

Prostate cancer: endogenous chemical castration.

We report treatment of intermediate risk prostate cancer in a patient with a brief period of androgen deprivation secondary to a pituitary adenoma. This was a patient with intermediate risk prostate cancer diagnosed in the setting of an elevated

(Visited 30 times, 1 visits today)
4
Like
Save

Comments

Write a comment

*